Concert Pharmaceuticals - Building Better Medicinse
Home About Us Research & Development Investors & Media Careers Contact Us
Research & Development


Product Pipeline


Product Pipeline

Our approach starts with approved drugs, advanced clinical candidates or previously studied compounds that we believe can be improved with deuterium substitution to provide better pharmacokinetic or metabolic properties and thereby enhance clinical safety, tolerability or efficacy. We have executed on this approach to become a clinical stage biotechnology company and are developing a robust pipeline of clinical candidates in several therapeutic areas.


[ back to top ]

  ©2009 Concert Pharmaceuticals, Inc.
Design by Digizyme
Home     Sitemap